VaR模型評估市場風險之個別風險有效性之實證研究－以權益證券商品為例
The empirical study on effectiveness of VaR model for Specific Risk in Basel II – A Case study of equity instrument
個別風險、風險值(VaR)、新巴塞爾資本協定、市場風險
為因應新巴塞爾資本協定對於金融機構採用內部模型法衡量市場風險的最新要求，即金融機構發展內部模型法必須加入個別風險(specific risk)，對權益證券商品而言，即為權益證券發行人個別因素所引起的市場風險，本文利用風險值衡量方法之Delta-Normal法與單一指標模型(Single-index Model)建構個別風險值衡量模型。根據新巴塞爾資本協定規範中對於金融機構採用內部模型法衡量市場風險時，必須利用回顧測試方法以驗證其模型的有效性，因此本文擬以財務危機事件作為主要的個別風險事件，針對發生財務危機事件的個股，在不同投資情境下進行個別風險值模型的回顧測試，以驗證此模型是否能有效衡量權益證券發行人因財務危機事件所引起的個別風險；根據本文的實證結果可知，本模型的回顧測試結果均符合新巴塞爾資本協定對內部模型法回顧測試規範標準之內，表示本研究所建構的個別風險值模型應能有效衡量權益證券商品的個別風險，將有助於因應新巴塞爾資本協定而欲採用內部模型法的金融機構之建置參考。
In response to the latest regulation by Basel II, financial institutions have to adopt the internal model approach for evaluating market risk, which means they need to consider one more criterion - specific risk - while developing the internal model. In equity product market, the new approach is to evaluate the market risk caused by equity securities issuer’s personal factors. This study attempts to build up a VaR model for specific risk by using two of market risk evaluation approaches Delta-Normal and Single-index Model.According to the regulations of Basel II, financial institutions should use Back Testing method to verify the effectiveness of the model while using internal model approach to evaluate market risk. Therefore, this study focus on a financial crisis happened as the specific risk, proceeding Back Testing of specific value-at-risk model in different investment circumstances to verify the effectiveness of this model in evaluation the specific risk caused by equity securities issuer’s financial crisis,Based on the empirical analysis, the outcome of back testing in this study fits in with the regulation of Basel II. This proves that this model is able to evaluate the specific risk of equity effectively, and that would be a valuable reference for financial institutions which intend to adopt the internal model approach in keeping up with the regulation of Basel II.
